About ODTx
The Total Solution for Sight-Threatening Retinal Diseases
On Demand Therapeutics, Inc. (ODTx™) was formed in May 2009 as a
unique joint venture between InterWest Partners, a leading
diversified venture capital firm, and MicroCHIPS, a developer of
intelligent implant systems. In addition to its own intellectual
property, ODTx has acquired exclusive ophthalmology rights to the
extensive patent portfolio and technical expertise developed by
MicroCHIPS in the areas of implantable drug delivery and monitoring
devices.
With its initial funding, ODTx has already demonstrated key
features of the delivery technology in vivo. ODTx is now
proceeding to create relationships with pharmaceutical and medical
device companies interested in developing differentiated ophthalmic
products based on this breakthrough drug delivery platform.
